Jasper Therapeutics 2026 annual meeting voting results; all proposals approved

Jasper Therapeutics, Inc.

Elected Judith Shizuru and Tom Wiggans as Class II directors with ~9.27M and ~9.28M votes for, respectively.
Ratified PricewaterhouseCoopers as independent auditor for FY2026 with 20.6M votes for (97.7% of votes cast).
Advisory say-on-pay approved with 9.0M for, 604k against, 73k abstain (excluding 11.4M broker non-votes).
Quorum of 75% (21.1M of 28.0M shares) represented at the July 31, 2026 meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.